Trials / Completed
CompletedNCT01806259
Ketorolac in Breast Cancer Surgery
Perioperative Ketorolac in High Risk Breast Cancer Patients With and Without Inflammation. A Prospective Randomized Placebo-controlled Trial.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Université Catholique de Louvain · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Do the use of Ketorolac in one intravenous injection at the moment of the operative incision reduce the number of recurrence in patient with advanced breast cancer without inflammation signs.
Conditions
- Curative Breast Cancer Surgery
- Inflammatory Positive/Negative Status
- Pre Surgical Incision Administration
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketorolac 30 mg IV | Active drug |
| DRUG | Placebos | Placebo looking like the Active drug |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2015-10-01
- Completion
- 2018-09-01
- First posted
- 2013-03-07
- Last updated
- 2020-04-07
- Results posted
- 2020-01-18
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01806259. Inclusion in this directory is not an endorsement.